Muscle-invasive transitional cell carcinoma of the urinary bladder: A population-based study of patterns of care and prognostic factors

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 1, 2001, Pages 23-30

  Scrimger, Rufus A ^a   Murtha, Albert D ^a   Parliament, Matthew B ^a,c   Venner, Peter M ^a   Hanson, John ^a   Houle, Greg ^b   Chetner, Michael ^b  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c FRCPC   (Canada)

Author keywords

Bladder; Carcinoma; Cystectomy; Prognosis; Radiotherapy

Indexed keywords

BIOPSY; CHEMOTHERAPY; PATIENT MONITORING; PATIENT TREATMENT; RADIOTHERAPY; SURGERY; TUMORS;

PROGNOSTIC FACTORS;

CELLS;

CARBOPLATIN; CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BONE MARROW SUPPRESSION; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ORGAN PRESERVATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0035450539     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01591-7     Document Type: Article

References (18)

1. Neoadjuvant chemotherapy for invasive bladder cancer: Prognostic factors for survival of patients treated with M-VAC with 5-year follow-up
2. Full-dose irradiation for patients with invasive bladder carcinoma: Clinical and histological factors prognostic of improved survival
3. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation
4. Treatment of T3 bladder cancer: Controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy
5. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy
6. The management of invasive transitional cell carcinoma of the bladder
7. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer
8. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis
9. Prognostic indices for bladder cancer: An analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy
10. Invasion depth is the most important prognostic factor for transitional cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy
11. The relationship of local control to distant metastasis in muscle invasive bladder cancer
12. Preoperative radiotherapy for muscle-invasive bladder carcinoma
13. Local recurrence after cystectomy alone for bladder carcinoma
14. Population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer
15. The management and outcome of bladder cancer in Ontario, 1982-1994
16. Bladder cancer: The selection of patients for treatment by full-dose irradiation
17. Biology and management of bladder cancer
18. Muscle-invasive bladder cancer treated with external beam radiotherapy: Prognostic factors